| Literature DB >> 36041504 |
Moran Duan1, Zhen Jin2.
Abstract
The emergence of mutant strains of COVID-19 reduces the effectiveness of vaccines in preventing infection, but remains effective in preventing severe illness and death. This paper established a heterogeneous mixing model of age groups with pharmaceutical and non-pharmaceutical interventions by analyzing the transmission mechanism of breakthrough infection caused by the heterogeneity of protection period under the action of vaccine-preventable infection with the original strain. The control reproduction number Rc of the system is analyzed, and the existence and stability of equilibrium are given by the comparison principle. Numerical simulation was conducted to evaluate the vaccination program and intervention measures in the customized scenario, demonstrating that the group-3 coverage rate p3 plays a key role in Rc. It is proposed that accelerating the rate of admission and testing is conducive to epidemic control by further fitting data of COVID-19 transmission in real scenarios. The findings provide a general modeling idea for the emergence of new vaccines to prevent infection by mutant strains, as well as a solid theoretical foundation for mainland China to formulate future vaccination strategies for new vaccines. This manuscript was submitted as part of a theme issue on "Modelling COVID-19 and Preparedness for Future Pandemics".Entities:
Keywords: COVID-19; Control reproduction number; Heterogeneous mixing; Prevent infection; Vaccination strategies
Mesh:
Substances:
Year: 2022 PMID: 36041504 PMCID: PMC9420055 DOI: 10.1016/j.jtbi.2022.111258
Source DB: PubMed Journal: J Theor Biol ISSN: 0022-5193 Impact factor: 2.405
Fig. 1Illustration of the basic modeling structure. The light green plane and light blue plane are the maps of COVID-19 transmission in age group- and , respectively. The rose lines represent age group- becomes age group- due to aging.
Description of variables and parameters.
| Variables | Description |
|---|---|
| Number of unvaccinated individuals who are fully susceptible in age group- | |
| Number of vaccinated non-responders in age group- | |
| Number of successful vaccinator in age group- | |
| Number of people whose immunity fails after the immune period in age group- | |
| Number of individuals who are in latent period without infectious in age group- | |
| Number of asymptomatic infections who have not been tested in age group- | |
| Number of symptomatic infections who have not been tested in age group- | |
| Number of people isolated after being tested positive for nucleic acid in age group- | |
| Number of hospitalized patients in age group- | |
| Number of individuals who recovered in age group- | |
| Total population. | |
| Parameters | Description |
| Natural birth rate/Natural death rate. | |
| Susceptibility of | |
| The number of contacts that a person in age group- | |
| Correction factor for the incidence of asymptomatic infection. | |
| Vaccination coverage in age group- | |
| Probability of successful vaccination in age group- | |
| Probability of lifetime immunity. | |
| Probability of | |
| Probability of | |
| Aging rate from group | |
| Protection period of vaccine in age group- | |
| The rate of | |
| The rate of | |
| The recover rate of | |
| Proportion of hospitalizations in age group- | |
| Length of hospital stay before recovery in age group- | |
| The rate of | |
| The rate of | |
| The rate of | |
Fig. 2Illustration of contact pattern. The left panel is contact pattern of 16 groups, and the right panel is 4 groups. The degree of color is proportional to the number of contacts.
Baseline values.
| Parameters | Values | Source |
|---|---|---|
| 2.1356e−05 | ||
| Derived from | ||
| 0.05 | ||
| [1/418.65 1/3510.06 1/17482.69 0] | ||
| [1/180 1/180 1/180 1/180] | ||
| [1/3 1/3 1/3 1/3] | ||
| [1/5.1 1/5.1 1/5.1 1/5.1] | ||
| [1/14 1/14 1/14 1/14] | Assumed | |
| [1/12.9 1/12.9 1/12.9 1/12.9] | Derived from | |
| [1/10 1/10 1/10 1/10] | ||
| [0.4 0.39 0.82 0.825] | ||
| [1/8 1/8 1/8 1/8] | ||
| [1/5 1/5 1/5 1/5] | ||
| [1/2.9 1/2.9 1/2.9 1/2.9] | ||
| 1/3 | The population of custom scenario is about 5.3 million, so | |
| 0.85 | Assumed | |
| [0.001 0.001 0.001 0.001] | Assumed |
Results of vaccination strategies.
| (A) | (B) | ||||||
|---|---|---|---|---|---|---|---|
| No. | Vaccination Strategy | TH.Cov | T( | TIR | TH.Cov | T( | TIR |
| M1 | – | – | – | – | – | – | |
| – | – | – | – | – | – | ||
| M2 | – | – | – | – | – | – | |
| – | – | – | – | – | – | ||
| M3 | – | – | – | – | – | – | |
| – | – | – | – | – | – | ||
| M4 | – | – | – | – | 329 | 78.06% | |
| – | – | – | – | ||||
| M5 | – | 315 | 94.34% | – | 228 | 88.01% | |
| – | – | ||||||
| M6-1 | 0.75 | 441 | 95.52% | 0.75 | 368 | 88.57% | |
| M6-2 | 0.1 | 325 | 94.45% | 0.1 | 238 | 87.94% | |
| M7-1 | 0.75 | 472 | 95.96% | 0.75 | 381 | 90.68% | |
| M7-2 | 0.1 | 327 | 94.42% | 0.1 | 239 | 88.05% | |
| M8-1 | 0.75 | 473 | 95.51% | 0.75 | 382 | 90.58% | |
| M8-2 | 0.1 | 327 | 94.42% | 0.1 | 239 | 88.05% | |
TH.Cov means threshold of coverage.
T() is the time when for the first time.
TIR is the abbreviation of total immunized ratio, which is equal to total number of vaccinations divided by N.
– means no data results during the whole experiment period.
stands for switching vaccination groups.
Fig. 3The 2D contour map of with . Panels (a)–(c) show the effect of simultaneous inoculation of “group-3 and group-4”, “group-3 and group-2”, and “group-4 and group-2” on respectively. The colorbar represents the value of .
Fig. 4Panels (a)–(c) represent the , magnitudes of gradient , negative gradient direction represented by streamline of “group-2 and group-3” strategy respectively.
Fig. 5Left panel is the 3D curved surface of , the upper part of light pink surface is . Right panel is slice map correspond with left panel, X–Y plane is coverage rate combination of group-2 and 3, -axis represents the change of , the colorbar is the value of .
Descriptions and estimations of initial variables and parameters of Shanghai outbreak.
| Initial variables | Values | Sources | Initial variables | Values | Sources |
|---|---|---|---|---|---|
| 1 220 144 | 0 | Assumed | |||
| 7 367 347 | Calculated | 16 313 409 | Calculated | ||
| 200 000 | LS | 28 500 | Assumed | ||
| 2982 | Assumed | 205 617 | |||
| 6921 | 1786 | ||||
| Parameters | Values | Sources | Parameters | Values | Sources |
| 2.3 | 1.9726e−05 | ||||
| 0.35 | 0.0081 | Calculated | |||
| 1/1.2 | 1/1.2 | ||||
| 1/5.64 | 1/8.2 | Calculated | |||
| 1/10 | 1/6 | ||||
| 1 | 1 | Assumed | |||
| 0.6393 | LS | 1/4.5 | LS | ||
| 1/4 | Assumed | 1/2.2 | |||
| 1/3 | Assumed | 0.85 | Assumed | ||
| 0 | Assumed | 0 | Assumed | ||
| 0.0137 | LS | 0 | Assumed | ||
Fig. 6The fitting results and PRCCs for Shanghai. Panel (a) is the fitting results of the reported local hospitalized cases in Shanghai from April 11 to May 16, 2022. Panel (b) is the value of partial rank correlation coefficient between control reproduction number and parameters , , , .